1993
DOI: 10.1016/0014-2999(93)90357-n
|View full text |Cite
|
Sign up to set email alerts
|

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

17
293
2

Year Published

1998
1998
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 687 publications
(312 citation statements)
references
References 19 publications
17
293
2
Order By: Relevance
“…It remains to be determined if other nonsteroid anti-inflammatory agents also enhance the developmental toxicity or vasoconstrictive actions of Coc. We have recently carried out experiments with the NOS inhibitor L-nitro-arginine-methyl-ester or the selective iNOS inhibitor aminoguanidine (Misko et al, 1993), and have likewise found enhanced effects of Coc upon hatchability and/or vasoconstriction (unpublished observations), supporting the tentative interpretation of our results, as discussed above.…”
Section: Discussionsupporting
confidence: 86%
“…It remains to be determined if other nonsteroid anti-inflammatory agents also enhance the developmental toxicity or vasoconstrictive actions of Coc. We have recently carried out experiments with the NOS inhibitor L-nitro-arginine-methyl-ester or the selective iNOS inhibitor aminoguanidine (Misko et al, 1993), and have likewise found enhanced effects of Coc upon hatchability and/or vasoconstriction (unpublished observations), supporting the tentative interpretation of our results, as discussed above.…”
Section: Discussionsupporting
confidence: 86%
“…However aminoguanidine also inhibits nNOS [42] and iNOS [43]. New compounds which inhibit formation of AGEs, break the AGE-crosslink or inhibit RAGE without affecting NO synthesis [44] need to be evaluated in prevention of nitrergic neuropathy.…”
Section: Discussionmentioning
confidence: 99%
“…A possible role of iNOS in this is suggested by studies of aminoguanidine. Aminoguanidine is a relatively selective inhibitor of iNOS [7] and has been found to inhibit the diabetes-induced increase in iNOS levels and nitric oxide production in retina [4]. Importantly, aminoguanidine has also been found to inhibit development of the microvascular lesions of diabetic retinopathy in diabetic dogs [8], rats [9,10] and mice (T. S. Kern, unpublished data).…”
Section: Introductionmentioning
confidence: 95%